MARKET

NVO

NVO

Novo-Nordisk A/S
NYSE
49.23
+1.59
+3.33%
Opening 11:42 02/09 EST
OPEN
50.13
PREV CLOSE
47.64
HIGH
51.09
LOW
49.08
VOLUME
19.12M
TURNOVER
--
52 WEEK HIGH
91.22
52 WEEK LOW
43.08
MARKET CAP
218.51B
P/E (TTM)
13.61
1D
5D
1M
3M
1Y
5Y
1D
Why Eli Lilly Stock Just Popped
NASDAQ · 49m ago
'Novo's Obesity Pill TV Ad Includes Misleading Claims, FDA Says'- Bloomberg
Benzinga · 1h ago
BUZZ-U.S. STOCKS ON THE MOVE-Edgewell, Waters Corp, Dynatrace
Reuters · 1h ago
FDA warns Novo Nordiskover ‘misleading’ Wegovy ad
TipRanks · 1h ago
Gottlieb says Hims & Hers risks DOJ action over unapproved GLP-1 rival to Novo Nordisk- CNBC interview
Seeking Alpha · 1h ago
BUZZ-Hims sinks to over-one-year low after Novo Nordisk patent‑infringement lawsuit
Reuters · 1h ago
Novo Nordisk Takes Legal Action Against Hims & Hers Over Wegovy Knock Offs
Benzinga · 2h ago
Novo Nordisk Files Lawsuit Against Hims & Hers
NASDAQ · 2h ago
More
About NVO
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Webull offers Novo Nordisk A/S (ADR) stock information, including NYSE: NVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVO stock methods without spending real money on the virtual paper trading platform.